YARW compared with VYNE: revenue, margins and what each company keeps, and the suppliers and customers both name

YARWYarrow Bioscience, Inc.

Mkt capRevenueRevenue

VYNEVYNE Therapeutics Inc.

Mkt capRevenueRevenue

Compare

YARWYarrow Bioscience, Inc.

VYNEVYNE Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

YARW

No earnings history for YARW.

VYNE

Reportimpliedrealized× implied

Aug 14 '26—▼−0.54%—

Jul 29 '26—▲+8.56%—

Nov 6 '25—▲+4.59%—

Aug 14 '25—▲+0.69%—

= impliedYARW realized, solidVYNE realized, hatchedOne scale, both sides: full bar = 9%× = |realized| ÷ impliedSource: market data

YARWYarrow Bioscience, Inc.

20.42▲+2.10%· post 20.42

Mkt cap$53.1MRevenue$97,000Q2 FY26Revenue$501,000FY24

VYNEVYNE Therapeutics Inc.

20.42▲+2.10%· post 20.42

ClosedOct 30 '26

Mkt cap—Revenue—Revenue—

Compare

ClosedOct 30 '26

YARWYarrow Bioscience, Inc.

VYNEVYNE Therapeutics Inc.

20.42▲+2.10%post 20.42

Price

20.42▲+2.10%post 20.42

$53.1M

Mkt cap

—

Q2 FY26$97,000

Revenue

—

FY24$501,000

Revenue

—

YARW20.42▲+2.10%vsVYNE20.42▲+2.10%ClosedOct 30 '26